Partner Content Partner Content Neurostimulation Devices Market will achieve 15% CAGR up to ... Neurostimulation Devices Market to reach $19bn by 2025
News NHS broadens access to haemophilia A drug Hemlibra More people living with haemophilia A will be able to get access to Roche/Chugai's Hemlibra thanks to a commissioning agreement with NHS England.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
